États-Unis · Plateformes & données · Finviz

BWXT Beats On Margins And Sets A Firmer 2027 Outlook, But Slowing Revenue And A Delayed New-Build Order Keep The Stock Near Its Lows

Publié par Finviz · États-Unis il y a 9 h

The quality of the beat holds up better than the revenue miss might suggest, although part of it came from below the operating line. Government Operations carried the quarter.…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

BWXT Beats On Margins And Sets A Firmer 2027 Outlook, But Slowing Revenue And A Delayed New-Build Order Keep The Stock Near Its Lows

À lire aussi

BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 52-Week Low - Here's What Happened

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Nasdaq-100 tumbles into its third correction this year as AI worries mount

Stock market after midterm elections: What S&P 500 history shows

BWXT Beats On Margins And Sets A Firmer 2027 Outlook, But Slowing Revenue And A Delayed New-Build Order Keep The Stock Near Its Lows

Partager

À lire aussi

BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 52-Week Low - Here's What Happened

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Nasdaq-100 tumbles into its third correction this year as AI worries mount

Stock market after midterm elections: What S&P 500 history shows